Orange County Symposium 2015
Orange County Symposium 2015
Location: Costa Mesa, CA
Dates: Saturday, October 17, 2015
Avenue of Arts Wyndham Hotel
Download 2015 Program:
Now in its seventh year, this one-day CME/CE conference, jointly sponsored by the American Society for Preventive Cardiology, will feature a comprehensive agenda addressing dyslipidemia, statin intolerance, hypertension, hypertriglyceridemia, clinical lipidology, cardiometabolic risk and Type II diabetes presented by our local and nationally recognized faculty.
- Protection from Recurrent Events: Lipid and Non-Lipid Strategies
- Novel Therapeutic Strategies: The PCSK9 Evolution
- Joint 2015 AHA/ACC/ASH Scientific Statement Treatment of Hypertension in Patients With Coronary Artery Disease
- Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease
- Understanding the NLA 2014-2015 Lipid Guidelines
- How to Manage Statin Intolerance
- Women and Heart Disease - A Fresh New Look
- Dietary Strategies & Physical Activity
- Focus on Cardiovascular Health - Not Disease
- Management of Blood Glucose in Type 2 Diabetes Mellitus
- Secondary Prevention in High Recurrent ASCVD
Register for the 2015 OC Sympo
Must be logged in to see ASPC member price
Volunteer Clinical Faculty
University of California, Irvine (UCI) School of Medicine
California Heart Associates
Newport Coast, CA
Director of Non-Invasive Cardiology, Cardiac Rehabilitation, and Bioethics Orange Coast
Memorial Medical Center
Fountain Valley, CA
Director, Diabetes/Lipid Management & Research Center
Huntington Beach, CA
Clinical Professor of Medicine Division of Endocrinology, Diabetes and Metabolism
University of California, Irvine School of Medicine
Co-Director, Diabetes Out-Patient Clinic UCI Medical Center
Professor and Director
Heart Disease Prevention Program, Division of Cardiology
Adjunct Professor of Epidemiology and Radiology
University of California, Irvine School of Medicine
Past President, American Society for Preventive Cardiology
Department of Family Medicine and Public Health
University of California San Diego
La Jolla, CA
Clinical Professor of Medicine
UC, Irvine School of Medicine
Director, Atherometabolic Research
Utah Foundation for Biomedical Research
President, Utah Medical Center
President, American Board of Clinical Lipidology
Salt Lake City, UT
Director, Weight Management Center
Houston Methodist Diabetes & Metabolism Institute
Associate Professor of Medicine
Center for Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart and Vascular Center
Baylor College of Medicine
Medical Director, Preventive Cardiology and Cardiac Rehab
Director, Women's Heart Center
Cardiology Fellowship Program Director
University of California, Irvine
Director of Nutrition University of California Preventive Cardiology Program
Associate Clinical Professor of Medicine, Cardiology
University of California Irvine School of Medicine
Professor of Medicine (Cardiology)
Director of Emory Heart Disease Prevention Center
Emory University School of Medicine
Professor of Global Health
Hubert Department of Global Health
Rollins School of Public Health at Emory University
Statement of Need/Program Overview
The curriculum will focus on enhancing clinical competence in the application of effective risk reduction and lipid management strategies for the primary and secondary prevention of cardiovascular disease (CVD). The faculty will explore the primary theme of CVD prevention and risk reduction through management of lifestyle, dyslipidemia, statin intolerance, hypertension, hypertriglyceridemia, clinical lipidology, cardiometabolic risk and Type II diabetes. Faculty will present didactic lectures and participate in panel discussion sessions to encourage interaction from the audience and maximum engagement from attendees. Case based roundtables will also engage the attendees and provide an interactive forum. Attendees will leave the meeting with practical solutions and strategies for managing their most challenging patients at risk for CVD.
The 7th Annual Orange County Symposium will target primary care physicians, nurses, nurse practitioners, pharmacists, dietitians and other healthcare professionals in medical specialties including, but not limited to, internal medicine, general and family practice, endocrinology, cardiology and lipidology.
Upon completion of the educational activity, participants should be able to:
- Outline current national and international guidelines and recommendations on the diagnosis, management and treatment of dyslipidemia, and non-lipid risks, including diabetes, hypertension and obesity.
- Differentiate the lipid and lipoproteins that contribute to atherosclerotic cardiovascular (ASCVD) risk and residual risk, including atherogenic cholesterol, lipoprotein(a), and optional measures of atherogenic cholesterol particles for at-risk individuals.
- Discuss evidence regarding triglycerides and TG-rich lipoproteins as risk factors for ASCVD, including the clinical implications for patient management.
- Describe our current understanding of the role of HDL-C.
- Describe the importance of lifestyle modification in the reduction of ASCVD risk.
- Recognize the gender differences in the evaluation, treatment and outcomes in ASCVD.
- Place in perspective the role of statin and non-statin pharmacologic therapies in reaching goals for the targets of therapy.
- Review current management options for of statin intolerant patients in clinical practice.
- Detail the biology of PCSK9 in LDL cholesterol metabolism and the mechanism of action and clinical trial evidence for the new PCSK9 inhibitors.
- Delineate how clinicians can use current concepts, technologies, medical tools and team approaches to customize and maximize therapeutic success in primary and secondary ASCVD prevention.
CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and The American Society for Preventive Cardiology. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 6.5 Contact Hours.
Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and The American Society for Preventive Cardiology.
AKH Inc., Advancing Knowledge in Healthcare is a provider approved by the California Board of Registered Nursing, Provider Number CEP12070, for 6.5 contact hours.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AKH Inc., Advancing Knowledge in Healthcare approves this knowledge‐based activity for 6.5 contact hour(s) (0.65 CEUs). UAN 0077-9999-15-025-L04-P.
AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dieticians (RDs) and dietetic technicians, registered (DTRs) will receive 6.5 continuing professional education unit (CPEU) for completion of this program/material. CDR Accredited Provider #AN008. The focus of this activity is rated Level 2. Learners may submit evaluations of program/materials quality to the CDR at www.cdrnet.org.
Criteria for Success
Statements of credit will be awarded based on the participant's attendance, participation in the pre/post-test and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form www.aspconline.org/ocsympo. You must participate in the entire activity to receive credit. Claim credit will be available until November 20, 2015. If you have questions about this CME/CE activity, please contact AKH Inc. at firstname.lastname@example.org.
Full notification of commercial support will be provided in the final program.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and ASPC specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of ASPC and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by ASPC and AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.
*Program subject to change
Avenue of the Arts Wyndham Hotel
3350 Avenue of the Arts
Costa Mesa, CA 92626
A room block is not set up for the conference, however, you may visit the website if you would like to reserve a room.
Daily self-parking is $6.00 and daily valet parking is $10.00 for OC Symposium attendees.
Becoming a sponsor of the 7th Annual Orange County Symposium will provide your company valuable exposure to primary care physicians, cardiologists, lipidologists, and endocrinologists who are on the frontline – managing patients with cardiometabolic risk factors.
Please email Amina Resheidat or call 904-309-6212 for more information.